Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray absorption, in the context of radiographic contrast, refers to the differential attenuation of X-ray photons as they pass through various tissues or materials within the body. This difference in absorption is fundamental to producing contrast in radiographic images, allowing visualization of internal structures based on their composition and density. Contrast agents are substances introduced into the body specifically to alter local x-ray absorption characteristics, either increasing (positive contrast) or decreasing (negative contrast) attenuation.
Enhancement or reduction of X-ray attenuation in specific tissues or regions of interest.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray Absorption (Radiographic Contrast).